68 related articles for article (PubMed ID: 5294303)
1. Comparative trial of live measles vaccines in Czechoslovakia.
Syrůcek L; Helcl J; Sejda J; Svandová E; Staninec M; Grantová H; Mertenová J; Mílek E; Mirovský J; Procházka J; Strauss J; Zdrazílek J
Bull World Health Organ; 1965; 32(6):779-89. PubMed ID: 5294303
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies of measles vaccines in a controlled trial in the USSR.
Bolotovskij VM; Nefedova LA; Gelikman BG; Zargaryants AT; Zetilova LP; Nastasina KT
Bull World Health Organ; 1966; 34(6):859-64. PubMed ID: 5296534
[TBL] [Abstract][Full Text] [Related]
3. WHO-supported comparative studies of attenuated live measles virus vaccines.
Cockburn WC; Pecenka J; Sundaresan T
Bull World Health Organ; 1966; 34(2):223-31. PubMed ID: 4161187
[TBL] [Abstract][Full Text] [Related]
4. Studies on attenuated measles-virus vaccines in Canada.
Nagler FP; Foley AR; Furesz J; Martineau G
Bull World Health Organ; 1965; 32(6):791-801. PubMed ID: 5294304
[TBL] [Abstract][Full Text] [Related]
5. A further study on measles vaccination in Nigerian children.
Hendrickse RG; Montefiore D; Sherman PM; Sofoluwe GO
Bull World Health Organ; 1965; 32(6):803-8. PubMed ID: 5294305
[TBL] [Abstract][Full Text] [Related]
6. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH
N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505
[TBL] [Abstract][Full Text] [Related]
7. [Comparative serological efficacy of the measles vaccine strains Edmonston-Zagreb, Schwarz and AIK-C in Togolese infants of 4-5 months and 8-10 months].
Tidjani O; Grunitzky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):873-84. PubMed ID: 1819435
[TBL] [Abstract][Full Text] [Related]
8. Controlled epidemiological study of live measles vaccines in Poland.
Polish Measles Vaccination Committee
Bull World Health Organ; 1971; 45(3):331-5. PubMed ID: 5316912
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the reaction-causing properties and the immunological and epidemiological effectiveness of Leningrad-16 and Schwarz live measles vaccines.
Bolotovskij VM; Zetilova LP
Bull World Health Organ; 1968; 39(2):293-8. PubMed ID: 4881072
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of three measles vaccines in Indian children.
Banerjee K; Shaikh N; Phadke M; Bedekar SS; Rauta SK; Mehta JM
Indian J Public Health; 1998; 42(4):113-9. PubMed ID: 10389523
[TBL] [Abstract][Full Text] [Related]
11. Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months.
Cutts FT; Monteiro O; Tabard P; Cliff J
Bull World Health Organ; 1994; 72(2):227-31. PubMed ID: 8205642
[TBL] [Abstract][Full Text] [Related]
12. Lack of efficacy of the standard potency Edmonston-Zagreb live, attenuated measles vaccine in African infants.
Kiepiela P; Coovadia HM; Loening WE; Coward P; Botha G; Hugo J; Becker PJ
Bull World Health Organ; 1991; 69(2):221-7. PubMed ID: 1860150
[TBL] [Abstract][Full Text] [Related]
13. Trial of Edmonston-Zagreb measles vaccine in infants aged under nine months.
Pongrithsukda V; Gluck R; Suwatanapongched S; Kaewmalung P; Muyakul J
Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):347-50. PubMed ID: 1818384
[TBL] [Abstract][Full Text] [Related]
14. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
[TBL] [Abstract][Full Text] [Related]
15. Trial of a reduced dose of measles vaccine in Nigerian children.
Wallace RB; Landrigan PJ; Smith EA; Pifer J; Teller B; Foster SO
Bull World Health Organ; 1976; 53(4):361-4. PubMed ID: 1086728
[TBL] [Abstract][Full Text] [Related]
16. Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccines.
Wegmann A; Glück R; Just M; Mischler R; Paroz P; Germanier R
Dev Biol Stand; 1986; 65():69-74. PubMed ID: 3556778
[TBL] [Abstract][Full Text] [Related]
17. Antibody response after measles immunization.
Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
[TBL] [Abstract][Full Text] [Related]
18. The sequence of vaccinations and increased female mortality after high-titre measles vaccine: trials from rural Sudan and Kinshasa.
Aaby P; Ibrahim SA; Libman MD; Jensen H
Vaccine; 2006 Apr; 24(15):2764-71. PubMed ID: 16457909
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells.
Just M; Berger R; Glück R; Wegmann A
Dev Biol Stand; 1986; 65():25-7. PubMed ID: 3549399
[TBL] [Abstract][Full Text] [Related]
20. [Measles vaccination with split vaccines and living vaccines (author's transl)].
Stehr K; Enders-Ruckle G; Spiess H
MMW Munch Med Wochenschr; 1975 Jul; 117(27):1159-64. PubMed ID: 808710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
